LAUNCHub Ventures
LAUNCHub Ventures, established in 2012 and headquartered in Sofia, Bulgaria, is a leading early-stage venture capital fund investing in technology startups in Central and Southeastern Europe. The firm focuses on Seed and Series A funding stages, with initial investments ranging from €300K to €2M, and the capacity to lead rounds up to €4M. LAUNCHub Ventures invests in scalable businesses with initial traction, led by passionate founders from the region, whether they are based in South-Eastern Europe or global startup hubs like London and San Francisco. The firm is known for its hands-on approach, providing extensive support to founders beyond capital, including a 'Series A academy' program to help portfolio companies reach milestones and secure follow-on funding. Since its inception, LAUNCHub Ventures has played a significant role in growing the CEE startup ecosystem and has attracted prominent international VC firms to follow its investments.
Mediately
Series A in 2022
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.
Mediately
Seed Round in 2017
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.
Mediately
Seed Round in 2015
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.
Mediately
Seed Round in 2014
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.